コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gulated in CD8(+) T cells from patients with hepatitis delta.
2 died of fulminant recurrent hepatitis B and hepatitis delta.
3 tion for fulminant recurrent hepatitis B and hepatitis delta.
4 valid surrogate endpoint in the treatment of hepatitis delta.
5 of chronic delta hepatitis, disappearance of hepatitis delta and B virus markers, and improvement in
7 relapses may occur after PEG-IFNa therapy of hepatitis delta and thus the term sustained virological
8 ve for HBV serologic markers were tested for hepatitis delta antibody (HDAb) at 2 time periods: 1988-
9 titis delta virus (HDV) encodes one protein, hepatitis delta antigen (deltaAg), a 195-amino-acid RNA
10 anched rod structure that is associated with hepatitis delta antigen (HDAg) in cells replicating HDV.
11 e used this method to examine the effects of hepatitis delta antigen (HDAg) on the ribozyme activitie
12 by these RNAs with the virus-encoded protein hepatitis delta antigen (HDAg) perform essential roles i
13 unbranched rodlike structure of HDV RNA and hepatitis delta antigen (HDAg), a basic, disordered, oli
14 of an elongation factor, in the presence of hepatitis delta antigen (HDAg), and in the presence of t
15 ly distinct forms of the sole viral protein, hepatitis delta antigen (HDAg), from the same open readi
16 roles of the two forms of the viral protein, hepatitis delta antigen (HDAg), in HDV RNA replication a
17 iated with the sole virally encoded protein, hepatitis delta antigen (HDAg), in infected cells; howev
18 rs a single coding region whose product, the hepatitis delta antigen (HDAg), is expressed in two isof
20 ws two essential forms of the viral protein, hepatitis delta antigen (HDAg), to be synthesized from a
21 s, whereas HDV RNA encodes a single protein, hepatitis delta antigen (HDAg), which is required for vi
33 wn antiparallel coiled-coils (those from the hepatitis delta antigen (PDB ID code 1A92) and the bovin
34 ring requirement for the de novo-synthesized hepatitis delta antigen and temperature dependence, we f
35 required for production of the viral protein hepatitis delta antigen long form (HDAg-L), which is nec
36 ion, combined with our previous finding that hepatitis delta antigen mRNA synthesis is likely perform
38 raction with and incorporation of free large hepatitis delta antigen, it was partially defective in h
39 ctor SL1 could be precipitated together with hepatitis delta antigen, suggesting the association of H
42 ), which encode the small and large forms of hepatitis delta antigens (S- and L-HDAg), respectively.
43 s (simian virus 40), as well as those of the hepatitis delta enveloped virus large form antigen, with
44 to analyze the clinical long-term outcome of hepatitis delta in relation to different antiviral treat
46 ual posttreatment rate of clinical events in hepatitis delta patients eligible for PEG-IFNa therapy i
47 gth HCV cDNA plasmid containing a cis-acting hepatitis Delta ribozyme to control 3' cleavage, and inf
48 of lHDAg is required for the assembly of the hepatitis delta viral particle, these results suggest th
49 012 (amber/W site) in the antigenomic RNA of hepatitis delta virus (HDV) allows two essential forms o
51 little information on the early kinetics of hepatitis delta virus (HDV) and hepatitis B surface anti
55 ge hepatitis delta antigen (HDAg-L) mediates hepatitis delta virus (HDV) assembly and inhibits HDV RN
57 679-nt genomic and antigenomic RNAs of human hepatitis delta virus (HDV) can fold into a rod-like str
68 n (deltaAg-S and deltaAg-L, respectively) of hepatitis delta virus (HDV) differ only in the 19-aa C-t
73 dates utilize self-cleaving ribozymes of the hepatitis delta virus (HDV) family for processing their
74 The circular genome and antigenome RNAs of hepatitis delta virus (HDV) form characteristic unbranch
75 As early as 5 days after DNA copies of the hepatitis delta virus (HDV) genome or even in vitro-tran
77 transfected with a cDNA expressing a mutated hepatitis delta virus (HDV) genome that could only repli
78 elf-cleaving sequences or ribozymes from the hepatitis delta virus (HDV) genomic RNA and its compleme
85 vere form of chronic liver disease caused by hepatitis delta virus (HDV) infection superimposed on ch
86 The sera of 46 Italian patients with chronic hepatitis delta virus (HDV) infection were analyzed for
89 ed that the replication of the RNA genome of hepatitis delta virus (HDV) involves redirection of RNA
111 haracterizations of genetic variations among hepatitis delta virus (HDV) isolates have focused princi
121 f the genomic and antigenomic ribozymes from hepatitis delta virus (HDV) requires divalent cation for
125 mogeneous RNA transcripts: one encodes a 3'- hepatitis delta virus (HDV) ribozyme and the other, used
126 f RNA-bound magnesium hydrate in crystals of hepatitis delta virus (HDV) ribozyme and to follow the e
131 A small ribozyme related in structure to the hepatitis delta virus (HDV) ribozyme occurs in a number
132 erous group II intron domain 5-domain 6, and hepatitis delta virus (HDV) ribozyme RNA constructs.
134 nd product forms of the cis-cleaving genomic hepatitis delta virus (HDV) ribozyme show a divalent met
143 ndary structures proposed for the cis-acting hepatitis delta virus (HDV) ribozymes contain four duple
147 m of regulation for the ribozyme activity of hepatitis delta virus (HDV) RNA in infected cells is unk
148 cleavage site in the antigenomic sequence of hepatitis delta virus (HDV) RNA is 33-nt downstream of t
151 pendent RNA replication and transcription of hepatitis delta virus (HDV) RNA, generating a full-lengt
153 ion of the 1,679-nucleotide (nt) unit-length hepatitis delta virus (HDV) RNAs in the livers of two HD
156 A host-mediated RNA-editing event allows hepatitis delta virus (HDV) to express two essential pro
159 We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during teno
161 ecific drugs are currently available against hepatitis delta virus (HDV), a defective virus leading t
163 on of replication of the RNA genome of human hepatitis delta virus (HDV), a series of linear RNAs con
165 ction of primary human hepatocytes either by hepatitis delta virus (HDV), a subviral agent that uses
166 a central role in the replication scheme of hepatitis delta virus (HDV), allowing the virus to produ
170 iral agent of human hepatitis B virus (HBV), hepatitis delta virus (HDV), requires only the envelope
171 mic and antigenomic RNA strands of the human hepatitis delta virus (HDV), where they serve a crucial
173 Lacking an RNA-dependent RNA polymerase, hepatitis delta virus (HDV), which contains a circular R
174 Such difficulties can be circumvented with hepatitis delta virus (HDV), which needs the HBV large e
175 s were similar to those observed for HBV and hepatitis delta virus (HDV), which shares the same L, M,
179 auliflower mosaic virus 35S promoter and the hepatitis delta virus antigenomic ribozyme with a downst
193 of the T7 promoter and upstream of the human hepatitis delta virus ribozyme domain, we inserted a com
194 formed molecular dynamics simulations on the hepatitis delta virus ribozyme in the product form and a
196 NA polymerase promoter and the autocatalytic hepatitis delta virus ribozyme of a transcription plasmi
197 gth HCV cDNA plasmid containing a cis-acting hepatitis delta virus ribozyme to control 3' cleavage.
198 ectivity of the plasmid, a cDNA encoding the hepatitis delta virus ribozyme was added to the 3' end o
199 btilis RNaseP and an artificial trans-acting hepatitis delta virus ribozyme were expressed as the exo
200 solated from the antigenomic sequence of the hepatitis delta virus ribozyme with the P2 and P3 stems
201 catalytic RNAs, the hairpin ribozyme and the hepatitis delta virus ribozyme, and that the shifts are
202 eet western yellows virus pseudoknot and the hepatitis delta virus ribozyme, despite distinct structu
206 rsistently normal; after several years, both hepatitis delta virus RNA and serum HBsAg became undetec
210 RNA-protein complexes (RNPs) formed by the hepatitis delta virus RNAs and protein, HDAg, perform cr
212 ame envelope proteins, hepatitis B virus and hepatitis delta virus use the sodium/taurocholate cotran
214 titis C virus, human immunodeficiency virus, hepatitis delta virus, and alanine aminotransferase leve
216 self-cleaving RNAs: the hammerhead, hairpin, hepatitis delta virus, and in vitro-selected lead-depend
217 ween a variety of catalysts that include the hepatitis delta virus, hammerhead, X motif and Tetrahyme
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。